Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyprexa in Pathological Gambling
NCT00438776Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Feb 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in gambling disorder (GD), sponsored by Lindner Center of HOPE. Started Feb 2007; status: completed.
02
Drugs
olanzapine
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT00438776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438776.